Statement from FDA on continuing efforts to maintain its strong oversight of generic drugs
date:Feb 25, 2019
is approved to ensure generic drugs meet these requirements. In addition, the FDA conducts inspections of manufacturing plants, ensuring compliance with the agency's requirements on good manufacturing practices.

The FDAs staff also continually monitors brand and generic drug products to make certain the medicines at all levels of the supply chain, from active pharmaceutical ingredients (API) to drug products being sold to consumers, are safe, effective, and high quality. In the event that repo

06/17 20:00